Antifungal Susceptibility of 596 Aspergillus fumigatus Strains Isolated from Outdoor Air, Hospital Air, and Clinical Samples: Analysis by Site of Isolation
Open Access
- 1 August 2005
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 49 (8) , 3495-3497
- https://doi.org/10.1128/aac.49.8.3495-3497.2005
Abstract
We analyzed the activities of six antifungal drugs (amphotericin B, itraconazole, voriconazole, posaconazole, caspofungin, and micafungin) against 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples. We did not find differences among the susceptibilities by site of isolation.Keywords
This publication has 14 references indexed in Scilit:
- Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patientsJournal of Medical Microbiology, 2004
- Comparison of Caspofungin and Amphotericin B for Invasive CandidiasisNew England Journal of Medicine, 2002
- Voriconazole versus Amphotericin B for Primary Therapy of Invasive AspergillosisNew England Journal of Medicine, 2002
- Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994–1999Diagnostic Microbiology and Infectious Disease, 2001
- Acquired itraconazole resistance in Aspergillus fumigatusJournal of Antimicrobial Chemotherapy, 2001
- In Vitro Susceptibility Testing Methods for Caspofungin against Aspergillus and Fusarium IsolatesAntimicrobial Agents and Chemotherapy, 2001
- In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosisJournal of Antimicrobial Chemotherapy, 1998
- Trends in the postmortem epidemiology of invasive fungal infections at a University HospitalJournal of Infection, 1996
- Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-beta-D-glucan synthaseAntimicrobial Agents and Chemotherapy, 1994
- Antimicrobial Susceptibility Testing of Six Clinical Isolates of AspergillusAntimicrobial Agents and Chemotherapy, 1976